AAAAAA

   
Results: 1-7 |
Results: 7
Gemcitabine/cyclophosphamide/5-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients: A southern Italy cooperative oncology group phase I/II study
Authors: Frasci, G D'Aiuto, G Comella, P Thomas, R Capasso, I Botti, G Cortino, GR De Rosa, V Comella, G
Citation: G. Frasci et al., Gemcitabine/cyclophosphamide/5-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients: A southern Italy cooperative oncology group phase I/II study, SEMIN ONCOL, 28(3), 2001, pp. 50-56
Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: A parallel dose-finding study
Authors: Frasci, G Comella, P D'Aiuto, G Thomas, R Capasso, I Elmo, M Botti, G Cortino, GR Lapenta, L De Rosa, V Vallone, P Petrillo, A Comella, G
Citation: G. Frasci et al., Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: A parallel dose-finding study, ANN ONCOL, 11(3), 2000, pp. 367-371
Identification of a new subset of cells exhibiting dendritic phenotypes inpatients affected by breast proliferative disorders
Authors: D'Apice, L De Berardinis, P Pasquinelli, R Capasso, I D'Aiuto, M D'Aiuto, G Anzisi, AM Favre, R Cermola, M Barba, P Guardiola, J
Citation: L. D'Apice et al., Identification of a new subset of cells exhibiting dendritic phenotypes inpatients affected by breast proliferative disorders, HUMAN IMMUN, 61(8), 2000, pp. 739-752
Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology group (SICOG) phase II study
Authors: Frasci, G D'Aiuto, G Comella, P Thomas, R Capasso, I Di Bonito, M Rivellini, F Carteni, G De Lucia, L Maiorino, L D'Aniello, R Frezza, P Lapenta, L Comella, G
Citation: G. Frasci et al., Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology group (SICOG) phase II study, BREAST CANC, 62(2), 2000, pp. 87-97
Changing patterns of breast cancer stage at diagnosis in Southern Italy: Hospital data as indicators of progressive changes
Authors: Montella, M Buonanno, M Biondi, E Crispo, A De Marco, M Tamburini, M Botti, G Fabbrocini, G Capasso, I D'Aiuto, G
Citation: M. Montella et al., Changing patterns of breast cancer stage at diagnosis in Southern Italy: Hospital data as indicators of progressive changes, PREV MED, 30(2), 2000, pp. 174-177
Cisplatin-epirubicin-paclitaxel weekly administration in advanced breast cancer: A phase I study of the Southern Italy Cooperative Oncology Group
Authors: Frasci, G D'Aiuto, G Comella, P Apicella, A Thomas, R Capasso, I Di Bonito, M Carteni, G Biglietto, M Lucia, LD Maiorino, L Piccolo, S Bianchi, U D'Aniello, R Lapenta, L Comella, G
Citation: G. Frasci et al., Cisplatin-epirubicin-paclitaxel weekly administration in advanced breast cancer: A phase I study of the Southern Italy Cooperative Oncology Group, BREAST CANC, 56(3), 1999, pp. 239-252
Circulating antibodies against the breast tumor marker GCDFP-15/gp17 in mammary carcinoma patients and in patients carrying benign breast conditions
Authors: Pasquinelli, R Barba, P Capasso, I D'Aiuto, M D'Aiuto, G Anzisi, AM De Berardinis, P Guardiola, J
Citation: R. Pasquinelli et al., Circulating antibodies against the breast tumor marker GCDFP-15/gp17 in mammary carcinoma patients and in patients carrying benign breast conditions, INT J CANC, 84(6), 1999, pp. 568-572
Risultati: 1-7 |